Kevin Silva
Internal Medicine · Greenwood Village, CONPI 1811425903
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 42.2% of the total. 2025 is the largest year on record at $789, 6.9 times the $115 reported in 2019.
Across 62 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$514
- Amgen$75
- Jazz Pharmaceuticals Inc.$68
- Merck$61
- Grifols USA, LLC$54
- Avadel CNS Pharmaceuticals, LLC$49
- plus $399 from 14 others
What the payments were for
- Food & beverage$1,219100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $514 |
| Amgen | 4 | $75 |
| Jazz Pharmaceuticals Inc. | 4 | $68 |
| Merck | 2 | $61 |
| Grifols USA, LLC | 2 | $54 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $49 |
| United Therapeutics Corporation | 2 | $47 |
| Verona Pharma, Inc. | 3 | $45 |
| Ambu Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Abiomed | 1 | $31 |
| Viatris Specialty LLC | 2 | $30 |
| Pfizer | 1 | $27 |
| Harmony Biosciences LLC | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Sebela Pharmaceuticals Inc. | 1 | $22 |
| GSK | 1 | $16 |
| Electromed, Inc. | 1 | $14 |
How this compares
$1,219 in reported general payments places this provider in the 85th percentile of 1,430 internal medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $5,918 |
| Metformin Hcl | 12 | $206 |
| Letrozole | 11 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $27 | $5,91820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Greenwood Village
- Floyd RussakGreenwood Village$18K
- Farah KhanGreenwood Village$9K
- Kenneth TompkinsGreenwood Village$8K
- Jordan WalkerGreenwood Village$7K
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
- Monica GrafalsAvon$401K
- Luke WebbColorado Springs$287K
- Samuel PiedadColorado Springs$154K
- Sophia AmbrusoLittleton$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.